Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: A multi-center, uncontrolled, open-label study

2016 ◽  
Vol 38 (4) ◽  
pp. 407-413 ◽  
Author(s):  
Sawa Yasumoto ◽  
Masahiro Shimizu ◽  
Katsuaki Sato ◽  
Atsuyo Kurata ◽  
Yotaro Numachi
Keyword(s):  
Newly Diagnosed ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Absence Seizures ◽  
Lamotrigine Monotherapy

scholarly journals Lamotrigine monotherapy in newly diagnosed epilepsy or recurrent epilepsy:A multi-center, open-label study

2014 ◽  
Vol 7 (1) ◽  
pp. 55-65 ◽  
Author(s):  
Takamichi Yamamoto ◽  
Seung Bong Hong ◽  
Masahiro Shimizu ◽  
Katsuaki Sato ◽  
Yotaro Numachi
Keyword(s):  
Newly Diagnosed ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Lamotrigine Monotherapy

Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas

2018 ◽  
Vol 18 (1) ◽  
pp. 58-64 ◽  
Author(s):  
Soham D. Puvvada ◽  
José Guillen-Rodriguez ◽  
Abhijeet Kumar ◽  
Lora Inclán ◽  
Kara Heard ◽  
...  
Keyword(s):  
Phase 2 ◽  
Newly Diagnosed ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Mantle Cell ◽  
Indolent Lymphomas

An Ongoing Phase 2, Multi-Centre, Open-Label, Study of WTX101 in Newly Diagnosed Wilson Disease Patients – Early Observations

2016 ◽  
Vol 64 (2) ◽  
pp. S145-S146
Author(s):  
K.H. Weiss ◽  
A. Ala ◽  
F. Askari ◽  
D. Bega ◽  
J. Bronstein ◽  
...  
Keyword(s):  
Wilson Disease ◽  
Phase 2 ◽  
Newly Diagnosed ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Ongoing Phase
Sign in / Sign up

Export Citation Format

Share Document